Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients
- PMID: 28603629
- PMCID: PMC5464339
- DOI: 10.1002/prp2.310
Anticholinergic drug exposure is associated with delirium and postdischarge institutionalization in acutely ill hospitalized older patients
Abstract
Several studies investigated the possible association between anticholinergic drugs and diverse clinical outcomes in older persons, but the results are inconsistent. The aim of this study was to investigate whether anticholinergic drug exposure is associated with delirium on admission, length of hospital stay, postdischarge institutionalization and in-hospital mortality in acutely ill hospitalized older patients. In this observational chart review study, we included acutely ill patients aged 65 and older who were admitted to the geriatric ward of the Erasmus University Medical Center, Rotterdam, The Netherlands, between 2012 and 2015 (n = 905). Anticholinergic drug exposure on admission was defined as the use of anticholinergic drugs, total number of anticholinergic drugs and anticholinergic drug burden score (ADB), quantified with the Anticholinergic Risk Scale (ARS), the Anticholinergic Cognitive Burden scale (ACB) and the list of Chew et al. (Chew). Logistic regression analyses were performed to investigate possible associations between anticholinergic drug exposure and the aforementioned outcomes. Analyses were adjusted for age, sex, comorbidities, non-anticholinergic drugs and delirium, where appropriate. Moderate and high ADB measured with the ARS were associated with delirium on admission with odds ratios (OR) of 1.70 (95% confidence interval (CI) = 1.16-2.49) and 1.83 (95% CI = 1.06-3.15), respectively. High ADB measured with the ARS was also associated with postdischarge institutionalization (OR = 2.43, 95% CI = 1.24-4.75). No associations were found using the ACB and Chew. Future studies are warranted to investigate the clinical usefulness of the ARS in reducing complications in older persons.
Keywords: Adverse effects; anticholinergic drug scoring systems; delirium; outcomes; physical function; prognosis.
Figures
Similar articles
-
Differences of anticholinergic drug burden between older hospitalized patients with and without delirium: a systematic review and meta-analysis based on prospective cohort studies.BMC Geriatr. 2024 Jul 12;24(1):599. doi: 10.1186/s12877-024-05197-6. BMC Geriatr. 2024. PMID: 38997670 Free PMC article.
-
Anticholinergic Drug Use on Admission and the Risk of In-Hospital Falls in Older Hospitalized Patients.Clin Interv Aging. 2022 Mar 15;17:277-285. doi: 10.2147/CIA.S357818. eCollection 2022. Clin Interv Aging. 2022. PMID: 35313670 Free PMC article.
-
Anticholinergic Drug Burden and Delirium: A Systematic Review.J Am Med Dir Assoc. 2021 Jan;22(1):65-73.e4. doi: 10.1016/j.jamda.2020.04.019. Epub 2020 Jul 20. J Am Med Dir Assoc. 2021. PMID: 32703688
-
Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures.Am J Geriatr Psychiatry. 2013 Aug;21(8):785-93. doi: 10.1016/j.jagp.2013.01.012. Epub 2013 Feb 6. Am J Geriatr Psychiatry. 2013. PMID: 23567395
-
Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.Drugs Aging. 2019 Jan;36(1):85-91. doi: 10.1007/s40266-018-0612-9. Drugs Aging. 2019. PMID: 30484239
Cited by
-
Anticholinergic Drugs in Geriatric Psychopharmacology.Front Neurosci. 2019 Dec 6;13:1309. doi: 10.3389/fnins.2019.01309. eCollection 2019. Front Neurosci. 2019. PMID: 31866817 Free PMC article. Review.
-
Differences of anticholinergic drug burden between older hospitalized patients with and without delirium: a systematic review and meta-analysis based on prospective cohort studies.BMC Geriatr. 2024 Jul 12;24(1):599. doi: 10.1186/s12877-024-05197-6. BMC Geriatr. 2024. PMID: 38997670 Free PMC article.
-
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan.Int J Clin Pharm. 2023 Oct;45(5):1252-1259. doi: 10.1007/s11096-023-01639-0. Epub 2023 Sep 15. Int J Clin Pharm. 2023. PMID: 37713027
-
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia.Eur J Clin Pharmacol. 2021 Feb;77(2):241-249. doi: 10.1007/s00228-020-02995-w. Epub 2020 Sep 15. Eur J Clin Pharmacol. 2021. PMID: 32935181 Free PMC article.
-
Anticholinergic Drug Exposure Increases the Risk of Delirium in Older Patients Undergoing Elective Surgery.Front Med (Lausanne). 2022 May 6;9:871229. doi: 10.3389/fmed.2022.871229. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35602472 Free PMC article.
References
-
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text revision. American Psychiatric Association, Washington, DC.
-
- American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Association, Arlington, VA.
-
- Boustani M, Campbell N, Munger S, Maidment I, Fox C (2008). Impact of anticholinergics on the aging brain: a review and practical application. Aging Health 4: 311–320.
-
- Campbell NL, Maidment I, Fox C, Kahn B, Boustani M (2013). The 2012 update to the Anticholinergic Cognitive Burden Scale. J Am Geriatr Soc 61(Suppl. 1): S142–S143.
LinkOut - more resources
Full Text Sources
Other Literature Sources